Literature DB >> 12543901

Kidney transplantation from related and unrelated living donors in a single German centre.

Adina Voiculescu1, Katrin Ivens, Gerd Rüdiger Hetzel, Markus Hollenbeck, Wilhelm Sandmann, Klaus Grabitz, Kai Balzer, Frank Schneider, Bernd Grabensee.   

Abstract

BACKGROUND: Organ transplantation began in 1954 with living related donation (LRD). Because of organ shortage from cadavers, unrelated kidney donation (LURD) has been proposed and shown to have good results despite complete HLA mismatching. This study aims to look at differences and similarities comparing LRD and LURD performed in our centre since the implementation of the German transplant law in 1997.
METHODS: Between January 1997 and July 2001, 62 out of 112 potential living donors and their recipients were accepted. Immunosuppression consisted of triple therapy (steroids, cyclosporin, mycophenolate) in patients with three or fewer mismatches, or quadruple therapy including mono- or polyclonal antibody treatment in patients with four or more mismatches or cytotoxic antibodies. LRD and LURD groups were compared for number and type of rejections, complications and kidney function at the end of observation (median 15.5 months, range 1-50 months).
RESULTS: Out of 112 pairs presenting, transplantation was performed in only 62 cases (55.4%). Reasons to deny transplantation were medical problems of the potential donors in 19, psychological problems in 13, recipient problems in seven and other reasons in 11 pairs. In 38 cases LRD transplantation and in 24 cases LURD transplantation was carried out. Recipient age was significantly lower in the LRD group (37.7+/-12.1 years) compared with the LURD group (53.6+/-7.8 years). Mean donor age was 49.7+/-9.2 years in the LRD group and 50.3+/-9.1 years in the LURD group (ns). The number of mismatches was lower in LRD (2.1+/-1) than in LURD (4.4+/-0.9) (P=0.001) transplantation. The acute rejection rate was similar in both groups (52.2 vs 54.2%). OKT3 and tacrolimus rescue therapy for more severe rejections was more often applied in the LRD group but the difference did not reach the level of significance. There were more infectious complications in LURD transplantation (66.7 vs 36.4%, P=0.036) and a trend towards more surgical complications in LRD transplantation (28.9 vs 8.3%, P=0.062). One graft was lost due to transplant artery thrombosis and one recipient died 4 months after transplantation subsequent to cerebral ischaemia. Both patients belonged to the LRD group. Creatinine values at the end of observation time were 1.76+/-0.6 mg/dl in the LRD group and 1.62+/-0.5 mg/dl in the LURD group (ns).
CONCLUSION: Although kidney transplantation from unrelated donors was performed with a lower HLA match and although the recipients were older, the results are equivalent to living related transplantation. Therefore, kidney transplantation from emotionally related living donors represents a valuable option for patients with end-stage renal disease. Careful selection of donors and recipients is a prerequisite of success.

Entities:  

Mesh:

Year:  2003        PMID: 12543901     DOI: 10.1093/ndt/18.2.418

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Could living unrelated renal transplantation ameliorate the actual shortage of organs in the Balkan region?

Authors:  I Rambabova-Busljetic; Z Popov; J Masin-Spasovska; A Sikole; Gj Selim; S Dohcev; N Ivanovski
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

2.  Living-donor kidney transplantation: the Freiburg experience.

Authors:  Oliver Drognitz; Johannes Donauer; Judith Kamgang; Peter Baier; Hannes Neeff; Christian Lohrmann; Martin Pohl; Ulrich Theodor Hopt; Günter Kirste; Przemyslaw Pisarski
Journal:  Langenbecks Arch Surg       Date:  2006-08-19       Impact factor: 3.445

3.  Kidney organ donation: developing family practice initiatives to reverse inertia.

Authors:  Emmanouil K Symvoulakis; Emilia Stavroulaki; Myfanwy Morgan; Roger Jones
Journal:  BMC Health Serv Res       Date:  2010-05-17       Impact factor: 2.655

4.  Living-unrelated donor renal transplantation: an alternative to living-related donor transplantation?

Authors:  Nadeem Ahmad; Kamran Ahmed; Mohammad Shamim Khan; Francis Calder; Nizam Mamode; John Taylor; Geoff Koffman
Journal:  Ann R Coll Surg Engl       Date:  2008-04       Impact factor: 1.891

5.  Living related and living unrelated kidney transplantations: A systematic review and meta-analysis.

Authors:  Nasser Simforoosh; Hamidreza Shemshaki; Mohammad Nadjafi-Semnani; Mehdi Sotoudeh
Journal:  World J Transplant       Date:  2017-04-24

6.  [Husband to wife renal transplantatation and pretransplant HLA immunization: about two cases].

Authors:  Asmaa Drissi Bourhanbour; Sanae Ouadghiri; Sara Bougar; Ouafae Atouf; Chahrazade Brick; Imane Yakhlef; Kaoutar Atiifis; Kaoutar El Morabit; Malika Essakalli
Journal:  Pan Afr Med J       Date:  2021-10-12

Review 7.  Renal transplantation from elderly living donors.

Authors:  Jacob A Akoh; Umasankar Mathuram Thiyagarajan
Journal:  J Transplant       Date:  2013-09-12

8.  Outcomes of spousal versus related donor kidney transplants: A comparative study.

Authors:  T Mittal; R Ramachandran; V Kumar; M Rathi; H S Kohli; V Jha; K L Gupta; M Minz; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2014-01

9.  Social and interpersonal relationship modifications after renal transplant. A statistic and epidemiologic evaluation.

Authors:  F Famà; E Micali; C Linard; M D Venuti; G Costantino; M Gioffrè-Florio
Journal:  J Prev Med Hyg       Date:  2013-12

10.  The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry - a retrospective study.

Authors:  Samar Abd ElHafeez; Marlies Noordzij; Anneke Kramer; Samira Bell; Emilie Savoye; José Maria Abad Diez; Torbjörn Lundgren; Anna Varberg Reisaeter; Julia Kerschbaum; Carmen Santiuste de Pablos; Fernanda Ortiz; Frederic Collart; Runolfur Palsson; Mustafa Arici; James G Heaf; Ziad A Massy; Kitty J Jager
Journal:  Transpl Int       Date:  2020-10-26       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.